DaVita Inc. (NYSE:DVA) Receives Average Rating of “Hold” from Brokerages

DaVita Inc. (NYSE:DVA) has been given an average rating of “Hold” by the five ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $162.80.

Separately, Barclays lifted their price target on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday.

Institutional Trading of DaVita

Large investors have recently bought and sold shares of the stock. Transcendent Capital Group LLC acquired a new position in DaVita in the third quarter worth $25,000. SBI Securities Co. Ltd. acquired a new position in DaVita in the fourth quarter valued at about $41,000. Coppell Advisory Solutions LLC lifted its stake in DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after buying an additional 100 shares during the period. Blue Trust Inc. lifted its stake in DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after buying an additional 119 shares during the period. Finally, Canada Post Corp Registered Pension Plan acquired a new position in DaVita in the fourth quarter valued at about $55,000. 90.12% of the stock is currently owned by institutional investors.

DaVita Price Performance

NYSE:DVA traded down $2.33 during mid-day trading on Tuesday, reaching $155.09. 141,211 shares of the stock were exchanged, compared to its average volume of 709,241. The business has a fifty day moving average price of $161.39 and a 200 day moving average price of $157.80. The firm has a market capitalization of $12.72 billion, a PE ratio of 16.73, a PEG ratio of 0.84 and a beta of 0.94. DaVita has a 1-year low of $119.42 and a 1-year high of $179.60. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA) last released its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 88.18% and a net margin of 6.53%. Research analysts expect that DaVita will post 9.71 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.